Pandemic worsened mental health conditions among healthcare workers

More than half of healthcare workers reported at least one adverse mental health condition tied to the public health crisis caused by COVID-19, new data from the CDC reveals.

The agency surveyed more than 26,000 public health care workers from March 29 through April 16, 2021, to assess their mental health. The survey asked about mental stressors since the start of the COVID-19 pandemic in March 2020.

Of the 53% who reported at least one adverse mental health condition in the previous two weeks, 32% reported depression, 30.3% reported anxiety, 36.8% reported PTSD and 8.4% reported suicidal ideation.

“Public health workers who reported certain workplace practices, such as long work hours and the inability to take time off, were more likely to have experienced symptoms of a mental health condition,” the CDC noted.

Worse still, nearly a quarter of healthcare workers reported feeling bullied, threatened or harassed because of work.

The findings are important because millions of healthcare workers plan to leave the industry after the pandemic, leaving a potentially damaging shortfall of qualified workers.

Adverse mental health conditions are linked to a number of job disruptions, including absenteeism, high turnover, lower productivity and lower morale, according to the CDC. The agency suggested expanding staffing size and implementing more flexible schedules, as well as implementing, evaluating and promoting the use of employee assistance programs to ease some of these burdens. 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.